Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2 - PubMed (original) (raw)

Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2

H Molina et al. Proc Natl Acad Sci U S A. 1996.

Abstract

Complement receptor 1 (CR1, CD35) and complement receptor 2 (CR2, CD21) have been implicated as regulators of B-cell activation. We explored the role of these receptors in the development of humoral immunity by generating CR1- and CR2-deficient mice using gene-targeting techniques. These mice have normal basal levels of IgM and of IgG isotypes. B- and T-cell development are overtly normal. Nevertheless, B-cell responses to low and high doses of a T-cell-dependent antigen are impaired with decreased titers of antigen-specific IgM and IgG isotypes. This defect is not complete because there is still partial activation of B lymphocytes during the primary immune response, with generation of splenic germinal centers and a detectable, although reduced, secondary antibody response. These data suggest that certain T-dependent antigens manifest an absolute dependence on complement receptors for the initiation of a normally robust immune response.

PubMed Disclaimer

References

    1. Eur J Immunol. 1995 Apr;25(4):1013-7 - PubMed
    1. Immunol Today. 1994 Sep;15(9):437-42 - PubMed
    1. Immunity. 1995 Jul;3(1):39-50 - PubMed
    1. Nature. 1995 Jul 27;376(6538):352-5 - PubMed
    1. Springer Semin Immunopathol. 1983;6(2-3):173-94 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources